Monetta Financial Services’s Vertex Pharmaceuticals VRTX Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2025
Q2 | – | Sell |
-2,000
| Closed | -$970K | – | 60 |
|
|
2025
Q1 | $970K | Hold |
2,000
| – | – | 0.86% | 32 |
|
|
2024
Q4 | $805K | Hold |
2,000
| – | – | 0.65% | 45 |
|
|
2024
Q3 | $930K | Hold |
2,000
| – | – | 0.79% | 34 |
|
|
2024
Q2 | $937K | Hold |
2,000
| – | – | 0.81% | 35 |
|
|
2024
Q1 | $836K | Sell |
2,000
-500
| -20% | -$209K | 0.76% | 41 |
|
|
2023
Q4 | $1.02M | Hold |
2,500
| – | – | 0.97% | 27 |
|
|
2023
Q3 | $869K | Hold |
2,500
| – | – | 0.95% | 30 |
|
|
2023
Q2 | $880K | Hold |
2,500
| – | – | 0.86% | 31 |
|
|
2023
Q1 | $788K | Hold |
2,500
| – | – | 0.84% | 30 |
|
|
2022
Q4 | $722K | Hold |
2,500
| – | – | 0.83% | 30 |
|
|
2022
Q3 | $724K | Sell |
2,500
-1,500
| -38% | -$434K | 0.82% | 29 |
|
|
2022
Q2 | $1.13M | Hold |
4,000
| – | – | 1.18% | 20 |
|
|
2022
Q1 | $1.04M | Hold |
4,000
| – | – | 0.87% | 24 |
|
|
2021
Q4 | $878K | Buy |
+4,000
| New | +$878K | 0.68% | 30 |
|
|
2018
Q2 | – | Sell |
-7,000
| Closed | -$1.14M | – | 53 |
|
|
2018
Q1 | $1.14M | Buy |
+7,000
| New | +$1.14M | 0.61% | 36 |
|